 Muhammad Aftab
Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aorta, Thoracic | 20 | 2025 | 280 | 4.030 |
Why?
| | Aortic Aneurysm, Thoracic | 14 | 2022 | 136 | 3.270 |
Why?
| | Cardiac Surgical Procedures | 14 | 2023 | 589 | 3.140 |
Why?
| | Blood Vessel Prosthesis Implantation | 12 | 2024 | 222 | 2.360 |
Why?
| | Postoperative Complications | 15 | 2025 | 2821 | 2.160 |
Why?
| | Aortic Aneurysm | 5 | 2020 | 70 | 1.820 |
Why?
| | Hospital Mortality | 14 | 2025 | 924 | 1.770 |
Why?
| | Cardiopulmonary Bypass | 6 | 2020 | 220 | 1.680 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 4 | 2022 | 28 | 1.400 |
Why?
| | Spinal Cord Ischemia | 9 | 2025 | 60 | 1.400 |
Why?
| | Endovascular Procedures | 8 | 2025 | 356 | 1.310 |
Why?
| | Loeys-Dietz Syndrome | 2 | 2019 | 6 | 1.180 |
Why?
| | Spinal Cord | 7 | 2025 | 376 | 1.150 |
Why?
| | Vascular Surgical Procedures | 5 | 2025 | 333 | 1.130 |
Why?
| | Thrombocytopenia | 2 | 2020 | 208 | 1.100 |
Why?
| | Acute Kidney Injury | 5 | 2025 | 820 | 1.030 |
Why?
| | Heart Valve Prosthesis Implantation | 4 | 2017 | 185 | 1.010 |
Why?
| | Aortic Valve | 8 | 2020 | 359 | 1.010 |
Why?
| | Aorta | 8 | 2025 | 424 | 0.980 |
Why?
| | Paraplegia | 5 | 2022 | 61 | 0.910 |
Why?
| | Heart Transplantation | 6 | 2023 | 715 | 0.890 |
Why?
| | Heart Valve Diseases | 4 | 2020 | 153 | 0.880 |
Why?
| | Thoracic Surgery | 8 | 2020 | 141 | 0.860 |
Why?
| | Extracorporeal Membrane Oxygenation | 4 | 2025 | 345 | 0.850 |
Why?
| | Spinal Cord Injuries | 4 | 2021 | 232 | 0.830 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2021 | 32 | 0.800 |
Why?
| | Shock, Cardiogenic | 2 | 2020 | 59 | 0.750 |
Why?
| | Dissection | 3 | 2020 | 55 | 0.710 |
Why?
| | Diazoxide | 5 | 2021 | 21 | 0.650 |
Why?
| | Blood Transfusion | 2 | 2020 | 393 | 0.630 |
Why?
| | Kidney Failure, Chronic | 3 | 2025 | 599 | 0.620 |
Why?
| | Aortitis | 1 | 2019 | 10 | 0.620 |
Why?
| | Spinal Cord Stimulation | 1 | 2019 | 8 | 0.610 |
Why?
| | Politics | 1 | 2020 | 102 | 0.600 |
Why?
| | Humans | 74 | 2025 | 141754 | 0.590 |
Why?
| | Reperfusion Injury | 4 | 2025 | 295 | 0.580 |
Why?
| | Perfusion | 3 | 2022 | 228 | 0.580 |
Why?
| | Aortic Valve Insufficiency | 1 | 2018 | 44 | 0.580 |
Why?
| | Creatinine | 1 | 2020 | 490 | 0.570 |
Why?
| | Length of Stay | 7 | 2025 | 1263 | 0.560 |
Why?
| | Middle Aged | 32 | 2025 | 34647 | 0.550 |
Why?
| | Ochronosis | 1 | 2017 | 1 | 0.540 |
Why?
| | Stroke | 4 | 2024 | 1158 | 0.540 |
Why?
| | Alkaptonuria | 1 | 2017 | 2 | 0.540 |
Why?
| | Erythropoietin | 4 | 2018 | 98 | 0.530 |
Why?
| | Retrospective Studies | 25 | 2025 | 16374 | 0.510 |
Why?
| | Coronary Artery Disease | 4 | 2025 | 702 | 0.510 |
Why?
| | Treatment Outcome | 19 | 2025 | 11181 | 0.500 |
Why?
| | Oral Submucous Fibrosis | 1 | 2016 | 2 | 0.490 |
Why?
| | Intraoperative Complications | 1 | 2017 | 148 | 0.480 |
Why?
| | Heart Diseases | 1 | 2019 | 335 | 0.480 |
Why?
| | Mouth Mucosa | 1 | 2016 | 90 | 0.470 |
Why?
| | Aged | 24 | 2025 | 24746 | 0.460 |
Why?
| | Cardiomyopathies | 1 | 2019 | 331 | 0.460 |
Why?
| | Male | 45 | 2025 | 70179 | 0.440 |
Why?
| | Aortic Rupture | 1 | 2014 | 28 | 0.440 |
Why?
| | Viscera | 1 | 2014 | 17 | 0.440 |
Why?
| | Career Choice | 5 | 2016 | 233 | 0.430 |
Why?
| | Coronary Artery Bypass | 3 | 2025 | 243 | 0.430 |
Why?
| | Aortic Valve Stenosis | 1 | 2017 | 245 | 0.430 |
Why?
| | Risk Assessment | 10 | 2024 | 3508 | 0.420 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 454 | 0.420 |
Why?
| | Internship and Residency | 7 | 2020 | 1240 | 0.420 |
Why?
| | Ischemia | 3 | 2021 | 415 | 0.410 |
Why?
| | Prognosis | 7 | 2020 | 4080 | 0.400 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 348 | 0.390 |
Why?
| | Time Factors | 11 | 2020 | 6966 | 0.390 |
Why?
| | Female | 37 | 2025 | 75943 | 0.390 |
Why?
| | Incidence | 4 | 2020 | 2806 | 0.370 |
Why?
| | Cardiovascular Diseases | 2 | 2023 | 2096 | 0.350 |
Why?
| | Neuroprotective Agents | 2 | 2025 | 142 | 0.340 |
Why?
| | Patient Selection | 4 | 2019 | 688 | 0.330 |
Why?
| | Risk Factors | 12 | 2025 | 10482 | 0.310 |
Why?
| | Neurons | 2 | 2020 | 1621 | 0.300 |
Why?
| | Hypothermia, Induced | 2 | 2022 | 92 | 0.300 |
Why?
| | Propensity Score | 3 | 2019 | 332 | 0.300 |
Why?
| | Receptors, Erythropoietin | 2 | 2018 | 20 | 0.280 |
Why?
| | Cerebrovascular Circulation | 3 | 2022 | 271 | 0.260 |
Why?
| | Heart-Assist Devices | 3 | 2019 | 562 | 0.260 |
Why?
| | Comorbidity | 3 | 2020 | 1664 | 0.250 |
Why?
| | Kidney | 1 | 2014 | 1482 | 0.250 |
Why?
| | Aortic Diseases | 2 | 2019 | 119 | 0.240 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1498 | 0.240 |
Why?
| | Adult | 21 | 2025 | 39391 | 0.240 |
Why?
| | Hospitals, Community | 1 | 2025 | 59 | 0.230 |
Why?
| | Specialties, Surgical | 2 | 2016 | 80 | 0.230 |
Why?
| | Reoperation | 3 | 2018 | 592 | 0.230 |
Why?
| | Neuromuscular Blocking Agents | 1 | 2025 | 25 | 0.230 |
Why?
| | Intensive Care Units | 2 | 2020 | 871 | 0.210 |
Why?
| | Organ Preservation Solutions | 1 | 2023 | 45 | 0.210 |
Why?
| | Community Health Services | 1 | 2025 | 233 | 0.200 |
Why?
| | Elective Surgical Procedures | 1 | 2025 | 195 | 0.200 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2025 | 141 | 0.200 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 34 | 0.200 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2025 | 188 | 0.200 |
Why?
| | Anastomosis, Surgical | 3 | 2019 | 159 | 0.200 |
Why?
| | Kaplan-Meier Estimate | 4 | 2019 | 910 | 0.190 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5212 | 0.180 |
Why?
| | Mice, Inbred C57BL | 7 | 2025 | 5909 | 0.180 |
Why?
| | Heart Valve Prosthesis | 1 | 2023 | 118 | 0.180 |
Why?
| | Replantation | 2 | 2018 | 31 | 0.180 |
Why?
| | Databases, Factual | 3 | 2025 | 1448 | 0.170 |
Why?
| | Tissue and Organ Procurement | 2 | 2022 | 317 | 0.170 |
Why?
| | Survival Rate | 4 | 2019 | 1972 | 0.170 |
Why?
| | Stents | 3 | 2022 | 531 | 0.170 |
Why?
| | Vascular Grafting | 1 | 2020 | 15 | 0.170 |
Why?
| | Education, Medical, Graduate | 2 | 2016 | 526 | 0.170 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2019 | 181 | 0.170 |
Why?
| | Heart Arrest, Induced | 2 | 2017 | 34 | 0.170 |
Why?
| | United States | 9 | 2025 | 15310 | 0.160 |
Why?
| | Surgeons | 2 | 2023 | 336 | 0.160 |
Why?
| | Cardiovascular Abnormalities | 1 | 2020 | 14 | 0.160 |
Why?
| | Subclavian Artery | 1 | 2020 | 28 | 0.160 |
Why?
| | Surveys and Questionnaires | 7 | 2020 | 5974 | 0.160 |
Why?
| | Carotid Artery, Common | 1 | 2020 | 30 | 0.160 |
Why?
| | Age Factors | 2 | 2020 | 3294 | 0.160 |
Why?
| | Beauty | 1 | 2020 | 20 | 0.160 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2020 | 45 | 0.160 |
Why?
| | Decision Support Techniques | 1 | 2024 | 431 | 0.160 |
Why?
| | Mitral Valve | 1 | 2020 | 98 | 0.150 |
Why?
| | Protein Kinase Inhibitors | 1 | 2025 | 919 | 0.150 |
Why?
| | Acidosis | 1 | 2020 | 102 | 0.150 |
Why?
| | Marfan Syndrome | 2 | 2017 | 43 | 0.150 |
Why?
| | Critical Care | 1 | 2025 | 650 | 0.150 |
Why?
| | Prosthesis Failure | 1 | 2020 | 125 | 0.150 |
Why?
| | Prosthesis-Related Infections | 1 | 2020 | 99 | 0.150 |
Why?
| | Mice | 10 | 2025 | 18109 | 0.150 |
Why?
| | Morbidity | 1 | 2020 | 322 | 0.150 |
Why?
| | Postoperative Period | 1 | 2020 | 361 | 0.150 |
Why?
| | Age Distribution | 1 | 2019 | 397 | 0.150 |
Why?
| | Early Diagnosis | 1 | 2020 | 244 | 0.150 |
Why?
| | Sex Distribution | 1 | 2019 | 381 | 0.150 |
Why?
| | Device Removal | 1 | 2020 | 141 | 0.150 |
Why?
| | Sepsis | 1 | 2025 | 621 | 0.150 |
Why?
| | Ultrasonography, Interventional | 1 | 2020 | 155 | 0.150 |
Why?
| | Pacemaker, Artificial | 1 | 2020 | 117 | 0.150 |
Why?
| | Acute Disease | 3 | 2017 | 1010 | 0.150 |
Why?
| | Thrombectomy | 1 | 2019 | 75 | 0.150 |
Why?
| | Reimbursement Mechanisms | 1 | 2019 | 83 | 0.140 |
Why?
| | Nerve Growth Factor | 1 | 2018 | 34 | 0.140 |
Why?
| | Vena Cava, Inferior | 1 | 2019 | 74 | 0.140 |
Why?
| | Nervous System Diseases | 1 | 2021 | 277 | 0.140 |
Why?
| | Heart Arrest | 1 | 2022 | 385 | 0.140 |
Why?
| | Machine Learning | 1 | 2024 | 556 | 0.140 |
Why?
| | Substance Abuse, Intravenous | 1 | 2019 | 122 | 0.140 |
Why?
| | Heart Atria | 1 | 2019 | 139 | 0.140 |
Why?
| | Risk | 1 | 2020 | 907 | 0.140 |
Why?
| | Reactive Oxygen Species | 1 | 2020 | 634 | 0.130 |
Why?
| | Apoptosis | 2 | 2018 | 2576 | 0.130 |
Why?
| | Catheterization | 1 | 2018 | 182 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 276 | 0.130 |
Why?
| | Terminally Ill | 1 | 2017 | 37 | 0.130 |
Why?
| | Multidetector Computed Tomography | 1 | 2017 | 40 | 0.130 |
Why?
| | Administration, Oral | 2 | 2018 | 803 | 0.130 |
Why?
| | Tracheostomy | 1 | 2019 | 142 | 0.130 |
Why?
| | Nicorandil | 3 | 2021 | 11 | 0.130 |
Why?
| | Population Surveillance | 1 | 2020 | 482 | 0.130 |
Why?
| | Neuroprotection | 1 | 2017 | 44 | 0.130 |
Why?
| | Prosthesis Design | 1 | 2019 | 339 | 0.130 |
Why?
| | Job Satisfaction | 2 | 2016 | 224 | 0.130 |
Why?
| | STAT3 Transcription Factor | 1 | 2018 | 212 | 0.130 |
Why?
| | Defibrillators, Implantable | 1 | 2020 | 306 | 0.130 |
Why?
| | Regional Blood Flow | 2 | 2019 | 498 | 0.120 |
Why?
| | Mitral Valve Insufficiency | 1 | 2017 | 73 | 0.120 |
Why?
| | Coronary Vessels | 1 | 2018 | 247 | 0.120 |
Why?
| | Heart Failure | 2 | 2019 | 2093 | 0.120 |
Why?
| | Lung Transplantation | 1 | 2019 | 322 | 0.120 |
Why?
| | Aneurysm, Infected | 1 | 2015 | 4 | 0.120 |
Why?
| | Respiration, Artificial | 1 | 2020 | 685 | 0.120 |
Why?
| | Fibrosis | 1 | 2018 | 542 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 374 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 371 | 0.110 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 569 | 0.110 |
Why?
| | Thrombosis | 1 | 2019 | 399 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1977 | 0.110 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2075 | 0.110 |
Why?
| | Echocardiography | 1 | 2017 | 648 | 0.110 |
Why?
| | Blood Vessel Prosthesis | 3 | 2022 | 139 | 0.110 |
Why?
| | Clinical Competence | 3 | 2020 | 1205 | 0.110 |
Why?
| | Renal Circulation | 1 | 2014 | 72 | 0.110 |
Why?
| | Mitochondria | 1 | 2020 | 979 | 0.100 |
Why?
| | Animals | 10 | 2025 | 37749 | 0.100 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4421 | 0.100 |
Why?
| | Logistic Models | 2 | 2019 | 2092 | 0.100 |
Why?
| | Chi-Square Distribution | 1 | 2014 | 521 | 0.100 |
Why?
| | Biomarkers | 2 | 2025 | 4190 | 0.100 |
Why?
| | Cohort Studies | 5 | 2025 | 5815 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 1048 | 0.090 |
Why?
| | RNA, Long Noncoding | 1 | 2014 | 173 | 0.090 |
Why?
| | Renal Insufficiency | 1 | 2014 | 169 | 0.090 |
Why?
| | Perception | 1 | 2015 | 378 | 0.090 |
Why?
| | Smoking | 1 | 2019 | 1603 | 0.090 |
Why?
| | Odds Ratio | 1 | 2014 | 1057 | 0.090 |
Why?
| | Body Mass Index | 1 | 2020 | 2385 | 0.090 |
Why?
| | Societies, Medical | 1 | 2016 | 859 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 467 | 0.090 |
Why?
| | Hypertension | 1 | 2020 | 1254 | 0.090 |
Why?
| | Up-Regulation | 3 | 2018 | 860 | 0.090 |
Why?
| | Chronic Disease | 1 | 2017 | 1820 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2903 | 0.080 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 1077 | 0.080 |
Why?
| | Learning | 1 | 2015 | 439 | 0.080 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 605 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 1123 | 0.080 |
Why?
| | Renal Dialysis | 1 | 2014 | 457 | 0.080 |
Why?
| | Decision Making | 1 | 2017 | 961 | 0.080 |
Why?
| | Survival Analysis | 3 | 2019 | 1320 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2014 | 719 | 0.080 |
Why?
| | Cells, Cultured | 1 | 2017 | 4212 | 0.080 |
Why?
| | Diverticulitis | 1 | 2009 | 8 | 0.080 |
Why?
| | Colostomy | 1 | 2009 | 28 | 0.080 |
Why?
| | Sigmoid Diseases | 1 | 2009 | 14 | 0.080 |
Why?
| | Intestinal Perforation | 1 | 2009 | 45 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2025 | 7923 | 0.070 |
Why?
| | Colectomy | 1 | 2009 | 107 | 0.070 |
Why?
| | Kidney Transplantation | 1 | 2014 | 678 | 0.070 |
Why?
| | Brain | 1 | 2020 | 2868 | 0.070 |
Why?
| | Recovery of Function | 2 | 2025 | 684 | 0.070 |
Why?
| | Operative Time | 2 | 2019 | 154 | 0.070 |
Why?
| | Melanoma | 1 | 2014 | 792 | 0.070 |
Why?
| | Aortography | 2 | 2019 | 54 | 0.070 |
Why?
| | Young Adult | 3 | 2020 | 13749 | 0.060 |
Why?
| | Physicians | 1 | 2015 | 942 | 0.060 |
Why?
| | Laparoscopy | 1 | 2009 | 463 | 0.050 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 5697 | 0.050 |
Why?
| | Raffinose | 1 | 2023 | 29 | 0.050 |
Why?
| | Allopurinol | 1 | 2023 | 68 | 0.050 |
Why?
| | Quality of Life | 1 | 2016 | 3014 | 0.050 |
Why?
| | Organ Preservation | 1 | 2023 | 112 | 0.050 |
Why?
| | Adenosine | 1 | 2023 | 253 | 0.050 |
Why?
| | Glutathione | 1 | 2023 | 362 | 0.050 |
Why?
| | Benzoates | 1 | 2021 | 49 | 0.040 |
Why?
| | Death | 1 | 2022 | 125 | 0.040 |
Why?
| | Monitoring, Intraoperative | 1 | 2021 | 65 | 0.040 |
Why?
| | Signal Transduction | 3 | 2020 | 5169 | 0.040 |
Why?
| | KATP Channels | 1 | 2021 | 20 | 0.040 |
Why?
| | United States Department of Veterans Affairs | 1 | 2025 | 711 | 0.040 |
Why?
| | Potassium Channels | 1 | 2021 | 149 | 0.040 |
Why?
| | Motor Activity | 1 | 2025 | 720 | 0.040 |
Why?
| | Imidazoles | 1 | 2021 | 255 | 0.040 |
Why?
| | Resource Allocation | 1 | 2020 | 51 | 0.040 |
Why?
| | Surgical Instruments | 1 | 2020 | 51 | 0.040 |
Why?
| | Suture Techniques | 1 | 2020 | 128 | 0.040 |
Why?
| | Collateral Circulation | 1 | 2019 | 20 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2021 | 492 | 0.040 |
Why?
| | Brachiocephalic Trunk | 1 | 2018 | 11 | 0.040 |
Why?
| | Axillary Artery | 1 | 2018 | 13 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2020 | 223 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 1041 | 0.040 |
Why?
| | Echocardiography, Transesophageal | 1 | 2019 | 128 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2019 | 241 | 0.030 |
Why?
| | Linear Models | 1 | 2020 | 858 | 0.030 |
Why?
| | Disease Progression | 2 | 2016 | 2800 | 0.030 |
Why?
| | Drug Synergism | 1 | 2018 | 375 | 0.030 |
Why?
| | Postoperative Care | 1 | 2019 | 280 | 0.030 |
Why?
| | Sternotomy | 1 | 2016 | 26 | 0.030 |
Why?
| | Vasodilator Agents | 1 | 2018 | 330 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2021 | 900 | 0.030 |
Why?
| | Adolescent | 3 | 2023 | 22130 | 0.030 |
Why?
| | Thoracoscopy | 1 | 2016 | 58 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 280 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2019 | 1321 | 0.030 |
Why?
| | Professional Autonomy | 1 | 2016 | 31 | 0.030 |
Why?
| | Blotting, Western | 1 | 2018 | 1234 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 60 | 0.030 |
Why?
| | Patient Safety | 1 | 2019 | 337 | 0.030 |
Why?
| | Ohio | 1 | 2015 | 140 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2018 | 1363 | 0.030 |
Why?
| | Diacylglycerol O-Acyltransferase | 1 | 2014 | 5 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2018 | 516 | 0.030 |
Why?
| | Heart | 1 | 2018 | 620 | 0.030 |
Why?
| | Carnitine | 1 | 2014 | 83 | 0.030 |
Why?
| | Phosphorylation | 1 | 2018 | 1774 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 339 | 0.030 |
Why?
| | Veterans | 1 | 2025 | 1525 | 0.030 |
Why?
| | Forecasting | 1 | 2015 | 384 | 0.030 |
Why?
| | Employment | 1 | 2015 | 181 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2014 | 510 | 0.020 |
Why?
| | RNA Interference | 1 | 2014 | 469 | 0.020 |
Why?
| | Insulin | 1 | 2023 | 2491 | 0.020 |
Why?
| | Triglycerides | 1 | 2014 | 514 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 627 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1656 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2014 | 528 | 0.020 |
Why?
| | Surgical Staplers | 1 | 2009 | 4 | 0.020 |
Why?
| | Surgical Stomas | 1 | 2009 | 7 | 0.020 |
Why?
| | Fat Necrosis | 1 | 2009 | 10 | 0.020 |
Why?
| | Intraoperative Period | 1 | 2009 | 68 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2009 | 112 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2014 | 2506 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3495 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2765 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2009 | 1027 | 0.010 |
Why?
|
|
Aftab's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|